Objectives: Explain the nature of facial aging and describe treatment selection based on phenotypic appearance and severity of sun damage, volume loss and laxity.
Introduction: Facial aging presents with 3 primary findings of different degrees of severity, including: 1. Sun damage, 2. Soft Tissue and Bony Volume loss and 3. Tissue Laxity. These changes present along a continuum of severity and are influence by facial movement, internal and external environment and genetics.
Materials / method: All patients presenting for facial rejuvenation at our practice are evaluated for the degree of sun damage, anatomic locations of volume loss, and severity of laxity. Treatments are recommended along a continuum based on the severity of the presenting findings.
Results: In the most severe cases of sun damage, fractional CO2 lasers or CO2 or erbium ablational lasers are recommended. For more modest damage, fractional 1927 nm laser is utilized. All deep and superficial fat compartments and areas of bone loss are addressed using a technique of injectable tissue replacement and rejuvenation (ITR2). For severe laxity, a deep plane facelift, along with submental incision. Any combination of superficial and sub-platysmal fat removal, anterior digastric reduction, submandibular gland reduction and/or platysmaplasty may be needed depending on findings.
Conclusion: The major physical findings associated with facial aging include photo-damage, volume loss and laxity. Facial motion creases the skin, but also leads to separation of layers. Internal and external environment affect the rate and severity of aging. Lastly, aging is superimposed on individual genetics. Aesthetic outcomes are improved when photodamage, volume loss and laxity are each addressed with the treatment tailored to the degree of severity of each of the major physical findings.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
是
请注明名称(个人,公司,学会等等): MicroAire cannulas, Nanocube, Mage Group, UK, Millennium Medical Technologies, MSF
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
是
请注明日期: pending
和审阅情况: MicroAire Cannulas, Nanocube, ITR2
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。